HebeCell

Natick, United States

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

$53.0M raised

Aug 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has HebeCell raised?

HebeCell has raised $53.0M in total funding. The most recent round was Series A. The last funding was announced in August 2021.

Who are HebeCell's investors?

HebeCell's investors include Jacobio Pharmaceuticals, Aceso Biotech Venture Fund.

Where is HebeCell headquartered?

HebeCell is headquartered in Natick, United States.

What does HebeCell do?

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

What stage is HebeCell at?

HebeCell is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 31, 2021.

MLA

"HebeCell — Funding & Investors." VCBacked, August 31, 2021, https://www.vcbacked.co/company/hebecell. Accessed July 2, 2026.

APA

VCBacked. (2021). HebeCell — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/hebecell

Wikipedia (cite web)

{{cite web |title=HebeCell — Funding & Investors |url=https://www.vcbacked.co/company/hebecell |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 31, 2021.